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Introduction: There has been an increasing need for the terminology for the conservative 
management of female pelvic floor dysfunction to be collated in a clinically-based consensus 
report. 
Methods: This Report combines the input of members and elected nominees of the 
Standardization and Terminology Committees of two International Organizations, the 
International Urogynecological Association (IUGA) and the International Continence Society 
(ICS), assisted at intervals by many external referees. An extensive process of nine rounds of 
internal and external review was developed to exhaustively examine each definition, with 
decision-making by collective opinion (consensus). Before opening up for comments on the 
webpages of ICS and IUGA, five experts from physiotherapy, neurology, urology, 
urogynecology and nursing were invited to comment on the paper.  
Results: A Terminology Report for the conservative management of female pelvic floor 
dysfunction, encompassing over 200 separate definitions, has been developed. It is clinically-
based with the most common symptoms, signs, assessments, diagnoses and treatments 
defined. Clarity and user-friendliness have been key aims to make it interpretable by 
practitioners and trainees in all the different specialty groups involved in female pelvic floor 
dysfunction.  
Ongoing review is not only anticipated but will be required to keep the document updated and 
as widely acceptable as possible. 
Conclusion: A consensus-based terminology report for the conservative management of 
female pelvic floor dysfunction has been produced aimed at being a significant aid to clinical 
practice and a stimulus for research. 
 




This consensus-based terminology report for the conservative management of female pelvic 
floor dysfunction aims to provide clarity to description of clinical practice and research.  
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There is currently no single document addressing the conservative management of female 
pelvic floor dysfunction in a comprehensive way. The report is based on, and follows on 
from, the terminology proposed by the International Continence Society (ICS) 
Standardization of Terminology of Lower Urinary Tract Function [1]. The Standardization of 
Terminology of Pelvic Floor Muscle Function and Dysfunction: Report from the pelvic floor 
clinical assessment group of the International Continence Society [2] and the International 
Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on 
the terminology for female pelvic floor dysfunction [3].  
 
The terminology in current use related to conservative management generally lacks 
uniformity, often because different disciplines use their own terminology. The range of terms 
in use can lead to uncertainty, confusion and unintended ambiguity. It hampers the ability to 
build a body of literature concerning conservative interventions, e.g. the terms “behavioral 
therapy”, “lifestyle intervention”, “conservative treatment”, “non-surgical treatment”, 
“physiotherapy”, “biofeedback”, and “pelvic floor muscle exercise” are often used 
interchangeably and, at times, incorrectly to describe both the same and different 
interventions. A more standardized terminology would aid inter-disciplinary communication 
and understanding. 
 
Existing published reports address some of the aspects of this topic, but there are some areas 
currently lacking in standardisation of terminology, e.g. Messelink et al [2] and Haylen et al 
[3] refer to evaluation and diagnostic terminology, but not treatment terminology. 
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There is a need for a more extensive description of management of pelvic floor and pelvic 
floor muscle (PFM) dysfunction than is currently provided in existing terminology reports. 
With the development of the evidence-base for conservative therapies in the management of 
pelvic floor dysfunction (PFD), especially treatment of conditions such as incontinence and 
pelvic organ prolapse, terminology linked with these managements has evolved but with 
regional and discipline variations. A consensus on currently accepted terminology is required. 
Elements in the title of the document need to be defined: 
 
Conservative: is restricted to non-surgical and non-pharmacological approaches. 
 
Management: will include the following aspects: a) Assessment: including history and 
physical examination and investigations; b) diagnosis, c) prevention and d) treatment of 
pelvic floor dysfunction.  
 
Pelvic floor: structures located within the bony pelvis: urogenital and anorectal viscera, 
pelvic floor muscles and their connective tissues, and nerves and blood vessels.  
 
Pelvic floor dysfunction: 
Following on from Messelink et al report from the pelvic floor clinical assessment group of 
the ICS [2], this report will focus on terminology of management of pelvic floor function and 
dysfunction including bladder and bowel dysfunction, POP, sexual dysfunction and pelvic 
pain [4]. Terminology regarding pelvic pain and anorectal dysfunction related to PFM 
dysfunction will align with the current working groups on chronic pelvic pain and anorectal 
dysfunction. Terminology will include symptoms, signs and investigations (expanding on the 
Messelink et al paper [2]; diagnoses of PFM-related conditions (avoiding duplication with 
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Haylen et al [3]); prevention and treatment (including new therapies, e.g. exercise and 
adjunctive therapies including equipment, and lifestyle modifications – not covered by 
Messelink et al [2] or Haylen et al [3]. 
 
Additional descriptions related to the terms used in this manuscript 
Clinicians/Practitioners  
Conservative management of PFD may be provided by clinicians or practitioners of different 
disciplines, commonly physiotherapists / physical therapists, nurses, midwifes and medical 
doctors. However, other professions e.g. fitness instructors and personal trainers may also 
have a role in both education, health promotion and prevention of PFD. Terminology related 
to the accepted names of professions and the different types of therapies must be specified 
and distinguished (e.g. ‘physiotherapy’ as a management provided by a registered 
physiotherapist, distinct from ‘conservative therapy’ and ‘exercises’ / ‘biofeedback’ which 
may be provided by any clinician). The emphasis in this document will be on management 
commonly undertaken by clinicians practicing conservative management. 
 
Multi-disciplinary approach 
Relating to, or involving, two or more disciplines that are usually considered distinct [5], e.g. 
physical therapy, urology, gynecology.  
 
Gender. With the increasing specificity and complexity of female diagnosis and management 
it can be argued that a gender specific report is needed. However many of the terms defined in 
this report are not gender specific and will be the same for males e.g. PFM training and 




All working group members were asked to provide terms that they knew existed in the area. 
After the first “brainstorming activity”, all terms were listed and grouped according to 
introduction, symptoms, signs, examination methods, investigations, diagnosis, prevention 
and treatment. All members were given the text to add more terms. Additional searching for 
omitted terms in existing terminology papers of the ICS and IUGA, Cochrane reviews and the 
2013 ICI document [6] were undertaken. Existing definitions of established terms from 
general medicine [7,8], physiotherapy [5] and exercise science were used where available. 
Only in situations where there was no existing terminology, were new definitions introduced.  
We have not referred to or described the responsiveness, reliability and validity of the 
measurement methods of symptoms, signs and evaluations, nor the evidence for treatment 
efficacy of any of the therapies defined.     
 
Agreement on the definitions was reached by consensus. Wherever possible, evidence based 
principles were followed. However, this was a challenge in conservative management as there 
are many suggested therapies that do not have proven effectiveness [9,10]. Discussion 
meetings with representatives of IUGA and ICS were held at the following annual meetings: 
IUGA Brisbane 2012, ICS Beijing 2012, IUGA Dublin 2013, ICS Barcelona 2013, IUGA-
AUGS Washington DC 2014, IUGA Nice 2015. 
 
It is recommended that acknowledgment of these standards in written publications related to 
conservative management of female pelvic floor dysfunction is read as follows: “Methods, 
definitions and units conform to the standards jointly recommended by the IUGA-ICS joint 
report on the terminology for the conservative and non-pharmacological management of 
female pelvic floor dysfunction, except where specifically noted”.  
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SECTION 1: ASSESSMENT 
1.1. Symptoms 
Symptom: Any morbid phenomenon or departure from the normal in structure, function or 
sensation, experienced by the woman and indicative of disease or a health problem. 
Symptoms are either volunteered by, or elicited from the individual, or may be described by 
the individual’s caregiver [3].  
 
1.1.A. Existing (defined) Symptoms   
(i) Urinary incontinence symptoms [3] 
(ii) Bladder storage symptoms [3] 
(iii) Sensory symptoms [3] 
(iv) Voiding and postmicturition symptoms [3] 
(v) Pelvic organ prolapse (POP) symptoms [3] 
(vi) Symptoms of sexual dysfunction [3] 
(vii) Symptoms of anorectal dysfunction
1
 [3]  
 (viii) Lower Urinary Tract Infection [3] 
 
1.1.B. Lower Urinary Tract Pain and/or Other Pelvic Pain2 
(i) Pain (in general): “An unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage” [13]. 
 
                                                 
1
 Terminology for Female Anorectal Dysfunction [11]. 
2
 Comprehensive definition of these terms is covered by Doggweiler et al [12].  
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(ii) Tenderness: sensation of discomfort with or without pain; discomfort elicited through 
palpation, indicates unusual sensitivity to pressure or touch [14].  
 
(iii) Acute pain: pain related to acute trauma, infection or other well-defined disease 
processes or conditions.  
 
(iv) Chronic pain: Persistent or continuous / recurrent pain for at least 6 months. If non-acute 
and central sensitization pain mechanisms are well documented, then the pain may be 
regarded as chronic, irrespective of the time period [15,16]. 
 
(v) Myalgia: muscle pain. Pelvic floor myalgia (a symptom) may be present with or without a 








                                                 
3
Symptoms of pelvic floor myalgia should be described in terms of location, quality, intensity, 
pattern, duration, frequency, moderating factors and associated symptoms. Pain details may 
include: 
a. whether pain is present at rest or mechanical in nature (related to muscle contraction or 
relaxation or body posture) and / or altered with change of posture (lying to sitting, sitting to 
standing) or movement (bending, walking, sexual activity). 
b. may be uni- or bilateral in nature. 





1.2. Signs  
Sign: Any abnormality indicative of disease or a health problem, discoverable on examination 
of the patient; an objective indication of disease or a health problem [1]. 
 
1.2.A. Existing (defined) signs   
(i) Urinary incontinence signs: [3] 
a. Urinary incontinence [3] 
b. Stress (urinary) incontinence [3] 
c. Urgency (urinary) incontinence [3] 
d. Extraurethral incontinence [3] 
e. Stress incontinence on prolapse reduction (occult or latent stress incontinence) [3] 
 
(ii) Pelvic organ prolapse signs: [3]  
a. Uterine/cervical prolapse [3] 
b. Vaginal vault (cuff scar) prolapse [3] 
c. Anterior vaginal wall prolapse [3] 
d. Posterior vaginal wall prolapse [3] 
 
 (iii) Other pelvic examinations/signs [3]:  
a. Vulval abnormalities [3]  
b. Urethral mucosal prolapse [3] 
c. Urethral caruncle [3] 
                                                                                                                                                        
4
 The evidence for the existence of trigger points is debated [17]. 
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d. Urethral diverticulum [3] 
e. Total vaginal length (TVL): the distance from the posterior fornix to hymen [19]. 
f. Valsalva maneuver: the action of attempting to exhale with the nostrils and mouth, or 
glottis closed [7]. Valsalva is usually performed with digital closure of the nose as in trying to 
equalize pressure in a plane. Straining / bearing down may have a similar meaning as 
Valsalva, however in practice straining/bearing down may be interpreted to mean pushing 
downwards and trying to relax the pelvic floor, as in defecating. 
g. Bimanual pelvic examination [3] 
h. Perineal elevation: inward (ventro-cephalad) movement of the vulva, perineum, and anus 
during e.g. PFM contraction.  
i. Perineal descent:  excessive dorso-caudal movement of the vulva, perineum, and anus e.g 
during cough, Valsalva or straining [20,3]. 
j. Trophic: promoting cellular growth, differentiation and survival [8]. This is the normal 
status of an organ, tissue or cell in regards to nutrition, size, number, form and function. A 
trophic urogenital tract is usually well-estrogenized. 
k. Atrophic: decrease from previous normal size of the body or a part, cell, organ, or tissue. 
An organ or body part's cells may be reduced in number, size or both. Atrophy of some cells 
and organs is normal at certain points in the life cycle. Other causes include malnutrition, 




(iv) Anal signs [11] 
 
(v) Abdominal signs 
                                                 
5
 Atrophy of urogenital tract is normal at certain points in the life cycle, mainly caused by 
aging and hypoestrogenism [8,21].   
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a. Bladder fullness/retention: abdominal palpation or suprapubic percussion may indicate a 
full bladder, however in overweight patients this may not be easily detected. 
b. Pelvic bone irregularities: indication of previous fracture or sacral agenesis. 
 
(vi) Neurological signs 
Abnormalities of the nervous system detected by physical examination which reflect an 
underlying neurological disease or injury. Examples of abnormal signs may include altered 
sensation, muscle tone or reflexes. If present, the patient should be referred for a full 
neurological examination. 
  
1.2.B. Pelvic Floor Muscle Function Signs   
(i) Normal pelvic floor muscles: have a level of constant resting tone (except just before and 
during voiding and defecation), symmetry and ability to voluntarily and involuntarily contract 
and relax.   
  
(ii) Normal pelvic floor muscle contractile function: a constriction and inward (ventro-
cephalad) movement of the pelvic openings. Normal, well-functioning pelvic floor muscles 
may demonstrate some (controlled or limited) downward dorsal perineal movement in 
response to increased intra-abdominal pressure in the absence of incontinence or pelvic organ 
prolapse. 
 
(iii) Muscle tone: state of the muscle, usually defined by its resting tension, clinically 
determined by resistance to passive movement [22-24]. Muscle tone has two components: 1) 
the contractile component, created by a low-frequency activation of a small number of motor 
units; 2) the viscoelastic component, which is independent of neural activity and reflects the 
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passive physical properties of the elastic tension of the muscle fiber elements and the osmotic 




a. Hypertonicity: an increase in muscle tone related to the contractile or viscoelastic 
components that can be associated with either elevated contractile activity and / or passive 
stiffness in the muscle [23,25]. The terms neurogenic hypertoncity and non-neurogenic 
hypertonicity are recommended to describe the diagnosis and inform management. 
b. Hypotonicity: a decrease in muscle tone related to the contractile or viscoelastic 
components that can be associated with either reduced contractile activity and / or passive 
stiffness in the muscle. The terms neurogenic hypotonicity and non-neurogenic hypotonicity 




                                                 
6
 Muscle tone is evaluated clinically as the resistance provided by a muscle when a pressure / 
deformation or a stretch is applied to it [22-24]. Muscle tone may be altered in the presence 
or absence of pain. There is no single accepted or standardised way to measure muscle tone, 
and there are no normative values. 
7
 The terms hyper- and hypotonicity are commonly used in neurology and muscle physiology. 
Messelink et al [2] introduced the terms overactivity and underactivity related to pelvic floor 
muscles. These terms are not defined with cut-off points, nor are based on comparison with 
normal populations. As activity can only relate to the active (i.e. contractile) portion of 
muscle tone, activity cannot be used interchangeably with muscle tone, unless it can be shown 
that the active component of the muscle is altered. If increased (over) or decreased (under) 
activity in the PFM can be demonstrated by EMG or another measure, then these terms may 
be used appropriately. 
 17 
(iv) Stiffness:  resistance to deformation [26]. Passive elastic stiffness is defined as the ratio 
of the change in the passive resistance or passive force (ΔF) to the change in the length 
displacement (ΔL) or ΔF/ ΔL [27]. The term should only be used if stiffness is measured 
quantitatively such as with instruments like dynamometry or myotonometry. 
 
(v) Tension: may have a similar meaning to tone and stiffness. Muscle tension can be 
increased or decreased due to exogenous factors such as the amount of pressure applied and 
endogenous factors such as thickness/ cross sectional area of the muscle itself, fluid present 
within the muscle (swelling, inflammation), position (e.g. standing versus sitting) or increased 
neural activity. 
 
(vi) Spasm: persistent contraction of striated muscle that cannot be released voluntarily. If the 
contraction is painful, this is usually described as a cramp. Occurs at irregular intervals with 
variable frequency and extent [28]. Spasm over days or weeks may lead to a contracture.  
 
(vii) Contracture: an involuntary shortening of a muscle. Clinically, a muscle cramp and 
contracture may appear similar, however contractures are electrically silent [29]. 
 
(viii) Cramp: a painful involuntary muscle contraction that occurs suddenly and can be 
temporarily debilitating. Pain is intense and localised. It tends to occur when the muscle is in 
the shortened position and contracting, is generated by motor units, and displays a high firing 
rate (20 – 150 Hz) 8 [29].                                                                                                                                                    
 
                                                 
8
 Muscle cramp either during or immediately after exercise is commonly referred to as 
“exercise associated muscle cramping” [30], however cramps are not specific to exercise. 
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(ix) Fasciculation: a single, spontaneous, involuntary discharge of an individual motor unit.  
The source generator is the motor unit or its axon, prior to its terminal branches. 
Fasciculations display an irregular firing pattern of low frequency (0.1 – 10 Hz) [29,5]. 
Clinically, fasciculations are recognised as individual brief twitches. They may occur at rest 
or after muscle contraction and may last several minutes.  
 
(x) Tender point: tenderness to palpation at soft tissue body sites [22]. 
 
(xi) Trigger point (TrP): a tender, taut band of muscle that can be painful spontaneously or 




(xii) Pelvic floor muscle dyssynergia [2]: incoordination of the pelvic floor muscles and 
another muscle group during a functional activity, for example, the pelvic floor muscles may 
not relax appropriately during micturition or defecation.   
 
(xiii) Non-functioning pelvic floor muscles (modified from Messelink et al.) [2]: a 
situation in which there is no pelvic floor muscle action measurable either on instruction to 
contract (inability) or as the absence of an automatic response to an increase in intra-
abdominal pressure. This condition can be based on any pelvic floor symptom and on the sign 
of a non-contracting or non-relaxing pelvic floor.  
                                                 
9
 Local or referred pain may be reproduced. An active TrP is said to have a characteristic 
“twitch” response when stimulated, however the twitch response to palpation has been shown 
to be unreliable [32]. The most reliable sign of a TrP is sensitivity to applied pressure. 
Trigger points are implicated in myofascial pain, however the validity of this theory is 
controversial and has recently been refuted [17]. 
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(xiv) Pelvic floor muscle injury (PFMI): on clinical palpation, PFMI is diagnosed when one 
or more of the following is present: 1. A discontinuity of the puborectalis muscle at its 
attachment to the inferior pubic ramus [33]; 2. A distance of > 3.5 finger widths between the 
two sides of puborectalis muscle insertion [34,35]; 3. A gap in the continuity of the 
pubovisceral muscle between the pubic rami and the anorectum [36]. 
 
(xv) Muscle action characteristics  
a. Maximal voluntary contraction (MVC): the attempt to recruit as many fibres in a muscle 
as possible for the purpose of developing force [37]. PFM MVC can be assessed by vaginal 
palpation, manometers and dynamometers
10
.  
b. Muscle strength: force-generating capacity of a muscle [5]. It is generally expressed as 
maximal voluntary contraction measurements and as the one- repetition maximum (1RM) for 
dynamic measurements [39,40,37].  
c. Local muscle endurance: the ability to sustain near maximal or maximal force, assessed 
by the time one is able to maintain a maximal static or isometric contraction, or ability to 
repeatedly develop near maximal or maximal force determined by assessing the maximum 
number of repetitions one can perform at a given percentage of 1 RM [41].                                                                                                 
d. Muscle power: the explosive aspect of strength; the product of strength and speed of 
movement (force x distance/time) [41]. 
e. Co-ordination: property of movement characterized by the smooth and harmonious action 
of groups of muscles working together to produce a desired motion [5].   
                                                 
10
 Palpation is less reliable and responsive than manometers and dynamometers [38]. 
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f. Motor control: the ability of the nervous system to control or direct the muscles in 
purposeful movement and postural adjustment by selective allocation of muscle tension 
across appropriate joint segments [5,42]. 
g. Submaximal contraction:  all contractions without maximal effort, expressed as a 
percentage of 1 RM.  
h. Synergistic contraction: the combination of several muscle actions that serve to optimally 
achieve a motor task [43].   
i. Co-contraction: contraction of two or more muscles at the same time.  Co-contraction of 
muscles can be synergistic (e.g. resulting in an augmentation of motor activity) or it could be 
counterproductive to normal function (e.g contraction of antagonistic muscles resulting in 
abnormal movement or training other muscles instead of the targeted ones; e.g. training of 
gluteal muscles instead of the PFM). 
j. Antagonistic contraction: contraction of muscle/muscle groups with opposite action to the 
wanted action (activity that hinders the targeted muscle/muscle group from contracting).  
 
(xvi) Other 
a. Hypertrophy: the increase in size (volume) of the muscle fibers [43].   
b. Atrophy: the decrease in size of muscle fibers as a result of inactivity, illness or aging 
[44].  
c. Bulk: the absolute volume of a muscle measured by imaging techniques such as anatomical 
magnetic resonance imaging and ultrasonography (US) [45]. 
d. Anatomic cross sectional area: for an individual muscle, the largest cross-sectional area 
along the length of that muscle and 90° on the muscle length [7]. 
e. Physiological cross-sectional area: the total area of cross-section perpendicular to the 
muscle fibers [7]. 
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f. Flexibility: the ability of a muscle to lengthen and allow one joint (or more than one joint 
in a series) to move through a range of motion.
 
Loss of flexibility is defined as a decrease in 
the ability of a muscle to deform [46]. 
g. Proprioception: sensory information from receptors of muscles, joints, capsules and 
ligaments that provides information related to posture and movement [47]. 
h. Exteroception: sensory information from receptors in the skin registering touch, vibration, 
heat, and cold [47].  
 
SECTION 2: INVESTIGATIONS AND IMAGING 
All methods and devices used for assessments (eg palpation, manometers, dynamometers, 
EMG, urodynamics, ultrasound and MRI) must be described in detail, and their 
responsiveness (ability to detect small changes), reliability and validity should be reported 
[38]. 
2.1. Existing (defined) investigations   
2.1.A. Urodynamics  
Functional study of the lower urinary tract [3]. 
 
 (i) Uroflowmetry [3] 
(ii) Post-void residual (PVR –urine volume) [3]  
(iii) Cystometry [3]  
(iv) Pressure flow study [3]  
(v) Assessment of Urethral Function [3] 
a. Urethral pressure measurement [3] 
b. Abdominal leak point pressure (ALPP) [3] 
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2.1.B. Frequency-volume chart (FVC) 
The recording of the time of each micturition and the volume voided for at least 24 h, 
although two or three days of recording (not necessarily consecutive) will generally provide 
more useful clinical data [3].  
 
(i). Bladder diary: In addition to the FVC, a bladder diary will include fluid intake, pad 
usage, incontinence episodes and the degree of incontinence [3].  
 
2.1.C. Pad testing 
Quantification of the amount of urine lost over the duration of testing, by measuring the 
increase in weight of the perineal pads (weighed pre-and post-testing) used [3].  
 
2.1.D. Ultrasound imaging  
(i) Pelvic floor muscle injury (PFMI): PFMI is diagnosed on ultrasound when at least one of 
the following is present: 1. Undetected puborectalis-to-ipsilateral sidewall attachment on any 
of the three central slices (full avulsion); 2. Undetected puborectalis-to-ipsilateral sidewall 
attachment on at least one slice (partial avulsion) [48]; 3. A levator-urethra gap (LUG) of 
greater than 2.5cm [49]. 
 
(ii) PFM position in the pelvis can be measured in the sagittal plane and can be related to 
PFM dysfunction (elevated or descended pelvic floor). 
 
(iii) Hiatal dimension is the cross-sectional area of the pelvic floor / levator hiatus, including 
antero-posterior and transverse distances. 
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Figure 1: Levator hiatal dimensions measured using trans-perineal ultrasound (with 
permission from Ingeborg Hoff Braekken) 
 
2.1.E. Radiological imaging   
Videocystourethrography (VCU); intravenous urography (IVCU); micturating cystography 
(MCU); defecography; colpo-cystodefecography. 
2.1.F.  Magnetic resonance imaging (MRI)  
(i) Pelvic floor muscle injury can represent a full spectrum from a disruption of a single 
fascicle, to complete disruption of the muscle origin. At present, there is no universally 
accepted system for diagnosis and evaluating the extent of the injury. Essentially, 
abnormalities are judged to have occurred when the morphology of the pubococcygeal portion 
of the levator ani muscle deviates from what is seen in normal nulliparous women [50]. 
Several groups studied and have defined levator damage on MRI when one or more of the 
following is present: Absence of pubococcygeal muscle fibers in at least one 4-mm section or 
two or more adjacent 2-mm sections in both the axial and coronal planes [51]. The degree of 
injury can be assessed based on the amount of muscle involved in the injury with reasonable 
repeatability among different examiners in a single group [52]. More than half the expected 
muscle bulk is associated with the presence of pelvic organ prolapse [53]. 
 
(ii) PFM position in the pelvis: location of the pelvic floor muscles in the sagittal plane in 
relation to defined landmarks. Can be elevated or descended.  
2.2. Palpation  
The process of using one’s fingers / hands as part of assessment, to gather information about 
the tissues. Digital palpation of the PFM is described by Messelink et al [2]. 
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Figure 2: Digital palpation of the pelvic floor muscles (with permission from subjects in photo 
and photographer Andreas Birger Johansen)  
 
2.3. Manometer 
A device to measure pressure.  
2.3.A. Pelvic floor manometry  
Measurement of resting pressure or pressure rise generated during contraction of the PFM 
using a manometer connected to a sensor which is inserted into the urethra, vagina or rectum. 
Pelvic floor manometric tools measure pressure in either mmHg, hPa or cmH2O
11
 [38]. 
Conversion of data to the international standard unit of measurement (hPa) is recommended. 
Figure 3: Peritron manometer (with permission from Laborie) 
 
Figure 4: Graphical illustration of pelvic floor muscle manometry readings (with permission 
from illustrator Ingeborg Hoff Braekken) 
 
(i) Perineometer: the first PFM vaginal pressure device connected to a manometer developed 
by Kegel
12
 [54].  
 
                                                 
11
 The pressure measured does not confirm its origin, and pressure measurement is only valid 
when used in combination with other methods e.g. simultaneous observation of inward 
movement of the perineum or device during PFM contraction. 
12
 The perineometer was developed by Kegel [54].The term perineometer is somewhat 
misleading as the pressure-sensitive region of the manometer probe is not placed at the 
perineum but inside the vagina at the level of the levator ani. Vaginal pressure devices should 
be referred to as PFM manometers [38,54]. 
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2.4. Dynamometer  
An instrument which measures power or force [8].  
 
2.4.A. Pelvic floor dynamometry 
Measurement of PFM resting and contractile forces using strain gauges mounted on a 
speculum (a dynamometer), which is inserted into the vagina [55]. Dynamometry measures 




.   
 
Figure 5: Ann Arbor, USA, dynamometer speculum. Note that the bills of the speculum are 
covered by a condom in actual use (with permission from Ashton-Miller JA, Zielinski R, 
DeLancey JO, Miller JM.) 
 
Figure 6: Montreal, Canada, dynamometer apparatus (with permission from Chantale 
Dumoulin) 
 
2.5. Electromyography (EMG) 
The recording of electrical potentials generated by the depolarization of muscle fibers. 
2.5.A. Electromyographic diagnosis   
State of the muscle (muscle pathology) by recording and analysing the electrical activity 
generated by the muscle
14
 [42]. 
                                                 
13
 Todays’ dynamometers for the pelvic floor also measures use of muscles other than the 
pelvic floor muscles. As dynamometers can be opened at different muscle lengths to measure 
PFM force, the process of measurement should respect the maximum achievable vaginal 
aperture without inducing discomfort, so as not to influence the validity of the measurement. 
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(i) Intra-muscular EMG: insertion of a wire or needle electrode into the muscle to record 
motor unit action potentials
15
.   
 
(ii) Surface electromyography: electrodes placed on the skin of the perineum or inside the 
urethra, vaginal or rectum
16
.   
Figure7: Verity Medical NeuroTrac Myoplus Pro surface EMG biofeedback apparatus (also 
incorporating electrical stimulation (with permission from Quintet, Norway) 
 
                                                                                                                                                        
14
 EMG in this case usually means “concentric needle EMG”, but other EMG methods exist. 
Electromyography is typically distinguished as intra-muscular or surface. Electromyographic 
diagnosis is often used as a synonym for “neurophysiological diagnosis of the peripheral 
neuromuscular system”, and that would also include measurement of motor and sensory 
conduction, recording of reflex responses etc [42]. EMG measurements are not a direct 
measure of muscle strength. The type of electrode being used should be specified. 
15
 This is not typically used in clinical assessment, but may be included in research or 
advanced examinations for example to diagnose striated muscle denervation/re-innervation 
[42]. 
16
 Surface EMG is considered to be less specific than intra-muscular EMG.  The large surface 
area of the electrodes may result in cross-talk from adjacent muscles, and other artifacts 
therefore technical expertise is required. EMG can reveal the pattern of activity of a 
particular muscle as in the diagnosis of detrusor sphincter dyssynergia during urodynamics 
[42,2].   
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 2.6. Pain assessment  
2.6.A. Pain evaluation  
Baseline and ongoing regular evaluation of severity, quality of life, thoughts, emotions and 
behavior associated with the pain (via direct consultation or questionnaires) and investigations 
to identify well-defined/confusable/non-pain syndromes. 
 
(i) Pain measurement 
Pain can only be measured subjectively. Patient-reported outcome measures include: 
a. Numerical rating scale (NRS), from 0 (no pain) to 10 (extreme pain), with half-points 
marked [56,57].  
b. Visual analogue scale (VAS), a 10-cm line with the same labels at the ends 
c. A simple verbal rating scale can be used, e.g. ‘none’, ‘mild’, ‘moderate’, ‘severe’17.  
 
(ii) Pain mapping: identifying pain generators through diagnostic procedures such as 
questionnaires, digital palpation, EMG, quantitative sensory threshold measurement, trigger 
point injections, nerve blocks and imaging.   
 
a. Questionnaires: several pain questionnaires  can be used in evaluation of musculoskeletal 
pain in the pelvis; the choice will be determined by which is most appropriate to the 
presenting pelvic floor dysfunction: McGill Pain Questionnaire [58], Pelvic Floor Distress 
InventoryPFDI [59], Female Sexual Function Index [60], Female Sexual Distress Scale [61], 
Pelvic Pain and Urgency/Frequency Questionnaire [62]. 
                                                 
17
 Because pain is multidimensional, a single rating scale combines these dimensions in 
unknown quantities. One may separately assess pain intensity, pain distress, and interference 
of pain with activities of daily life. 
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b. Pain chart / body map:  a simple line drawing of an outline of the front and back (or 
relevant body part) of the human body, onto which the patient sketches or ticks or marks areas 
of bodily pain to demonstrate the site and extent of perceived pain [63]. 
c. Pain checklist: a list of anatomical locations from which the patient selects relevant sites to 
his/her complaint. 
d. Measurement of muscle tone: there is no single tool which is able to measure all 
components of muscle tone. Some tools may be able to measure aspects of tone such as 
contractility, stiffness or elasticity. Instrumented methods may have a role in the valid and 
reliable evaluation of muscle tone e.g.  Surface electromyography (sEMG), wire and 
concentric electromyography, dynamometry, real-time ultrasound, elastometry, 
myotonometry. 
e. Trigger point (TrP) injection or needling: a diagnostic test to confirm if the identified 
TrP is a pain generator. The technique is the same as used in TrP treatment. 
f. Imaging: tissue-specific evaluation to identify if morphological trauma or deficit is present, 
which may relate to the presenting pain. Types of imaging may include X-Ray, ultrasound 
and MRI.  
 
SECTION 3: DIAGNOSES 
Diagnosis: the act or process of identifying or determining the nature and cause of a disease or 
injury through evaluation of patient history, examination and review of laboratory data and 
the opinion derived from such an evaluation [64]. 
 
A diagnosis for female PFD is based on the information obtained from the patient’s 
symptoms, signs, and any relevant diagnostic investigations. For the terminology of the 6 
most common PFD diagnoses; urodynamic stress urinary incontinence (USI), detrusor 
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overactivity (DO), pelvic  organ prolapse (POP), voiding dysfunction, bladder oversensitivity 
and recurrent UTI, the reader is directed to Haylen et al [3].  
 
3.1. Additional anorectal diagnosis    
(i) Local (fissures, hemorrhoids) [11]  
(ii) Fecal incontinence [11]  
(iii) Obstructed defecation syndrome [11] 
(iv) Rectocele [11] 
(v) Enterocele/sigmoidocele [11] 
(vi) Intussusception [11] 
(vii) Internal mucosal prolapse [11]  
(viii) Abscess/fistula[11]  
 
3.2. Pain syndromes 
 (i) Chronic pelvic pain syndrome (CPPS): persistent pain perceived in structures related to 
the pelvis, in the absence of proven infection or other obvious local pathology that may 
account for the pain.  It is often associated with negative cognitive, behavioural, sexual or 
emotional consequences, as well as with symptoms suggestive of lower urinary tract, sexual, 
bowel or gynecological dysfunction [16]. 
 
(ii) Chronic pelvic floor muscle pain syndrome: the occurrence of persistent or recurrent, 
episodic, pain in the PFM, in absence of proven or well-defined local pathology. It is often 
associated with negative cognitive, behavioural, sexual or emotional consequences, as well as 
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with symptoms suggestive of lower urinary tract, sexual, bowel or gynaecological 
dysfunction
18
 [16].  
 
3.3. Female sexual dysfunction  
Any departure from normal sensation and/or function expressed by a woman during sexual 
activity [3]. 
(i) Dyspareunia [3] 
(ii) Obstructed intercourse [3] 
(iii) Vaginal laxity [3] 
 
SECTION 4: TREATMENTS 
4.1. General terms  
 
                                                 
18
 Other urological, gynaecological, gastro-intestinal and colo-rectal pain conditions without 
related PFD, are well described in standard texts. Many pelvic floor pain-related conditions 
or syndromes (e.g. vulvodynia, interstitial cystitis/bladder pain syndrome, irritable bowel 
syndrome) are described in the Standard for Terminology in Chronic Pelvic Pain Syndromes 
(CPPS): A Report from the Ad Hoc Working Group of the International Continence Society 
Standardization Steering Committee (ICS-SSC) on Chronic Pelvic Pain ICS Standardization 
of Terminology document on Chronic Pelvic Pain [12]. Several other systemic disorders (e.g. 
chronic fatigue syndrome, diabetes) may impact on the pelvic floor, however pelvic floor 
dysfunction is not part of their recognized etiology. 
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4.1.A. Behavioral 
The way someone behaves, especially towards other people, and behavioral science is the 
study of human behavior [65].  
 
 (i) Behavior therapy: a kind of psychotherapy that attempts to modify observable 
maladjusted patterns of behavior by substituting a new response or set of responses to a given 
stimulus. The treatment techniques involve the methods, concepts, and procedures derived 
from experimental psychology; they include assertiveness training, aversion therapy, 
contingency management, flooding, modelling, operant conditioning and systematic 




(ii) Cognitive therapy: any of the various methods of treating mental and emotional 
disorders that help a person change attitudes, perceptions and patterns of thinking, from 
rational to realistic thoughts about self and situations. The technique is often used in 
association with behavior therapy principles. This approach is called cognitive behavior 
therapy [14]. 
 
(iii) Cognitive behavior therapy (CBT): a collective term for a range of psychotherapeutic 
techniques that attempt to use a problem-solving approach to the identification of thoughts 
and behaviors that underpin psychological problems or disorders [14].  
 
                                                 
19
 We recommend that “behavioral” be limited to studies that evaluate how people do or do 
not behave as desired e.g. commencement or cessation of pelvic floor muscle training or 
change of a diet. 
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4.1.B. Physiotherapy 
Physiotherapy involves “using knowledge and skills unique to physiotherapists” and, “is the 
service only provided by, or under the direction and supervision of a physiotherapist”20 [66].  
 
4.1.C. Adherence  
The extent to which a client/patient’s behaviour corresponds to the agreed treatment protocol 
and/or regime as recommended by their healthcare provider [67]. It does not refer to the 
intervention itself, rather, the patient’s commitment to undertaking the behavioural change in 




4.1.D. Compliance   
The extent to which a client/patient’s behaviour matches, or complies with, their healthcare 
provider’s recommended treatment protocol and/or regime22 [68]. 
                                                 
20
 We recommend that the specific treatment is described e.g. pelvic floor muscle training, 
electrical stimulation rather than the unspecific term physiotherapy; the latter also referring 
to a specific profession. Publications should report the actual professional who provided the 
intervention (e.g., physiotherapist, general practitioner, urogynecologist, urologist, midwife, 
nurse, fitness instructor), rather than using the vague term, “therapist” / “clinician” / 
“researcher”.   
21
 Adherence is usually reported as the number or percentage of (1) clinical visits attended 
and (2) home exercises or regimen components followed or completed by the client/patient. 
22
 The term ‘adherence’ is generally preferred within healthcare as it acknowledges 
client/patient autonomy and implies a willingness on their part to participate and cooperate 
rather than the traditional view, inherent in ‘compliance’, of an expert clinician dictating to a 
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4.1.E. Combination therapy (also known as polytherapy, multimodal therapy or combined 
modality therapy) 
Combination therapy is the use of more than one intervention concurrently for a single 
condition with one or multiple symptoms, for example a combination of medication with 
PFM training (PFMT).  
 
(i). Adjunctive therapies: any treatment or modality used to augment or assist the main 
treatment. In conservative treatments, adjunctive therapies often refer to equipment or a 
secondary therapy used to supplement the effect of the primary therapy, e.g. biofeedback-
assisted pelvic floor muscle training or neuromuscular electrical stimulation to augment 
PFMT. 
 
4.1.F. Prevention  
The act of preventing; decreasing the risk of disease or disability. Activities that are directed 
toward slowing or stopping the occurrence of both mental and physical illness and disease, 
minimizing the effects of a disease or impairment on disability, or reducing the severity or 
duration of an illness [5]. 
 
(i) Primary prevention: prevention of the development of disease in a susceptible or 
potentially susceptible population through such specific measures as general health promotion 
efforts [5]. 
                                                                                                                                                        
naive patient [67,68].Simply, adherence is agreeing what to do, compliance is being told 




(ii) Secondary prevention: efforts to decrease the duration of illness, reduce severity of 
diseases, and limit sequelae through early diagnosis and prompt intervention [5]. 
 
(iii) Tertiary prevention: efforts to limit the degree of disability and promote rehabilitation 
and restoration of function in patients/clients with chronic and irreversible diseases) [5].  
 
4.2. Lifestyle 
4.2.A.  Lifestyle modification  
The application of interventions in management of lifestyle-related health problems e.g. 
change to healthy diet and regular participation in physical activity and smoking cessation. 
The following lifestyle modifications may be applied to treat pelvic floor dysfunctions, either 
in combination with other therapies or as ‘stand-alone’ treatments.  
 
(i) Fluid consumption/restriction:  fluid consumption is the intake of fluid over 24 hours.  
Fluid restriction is the limitation of fluid to a prescribed amount over a period of 24 hours. 
These measures are often undertaken as part of a bladder training process. 
 
(ii) Dietary modification: an alteration or adjustment of food to treat bowel disorders (e.g. 
constipation and faecal incontinence) or urinary disorders (e.g. incontinence or urgency), e.g. 
increase of fibre to treat constipation. Specifics of the dietary changes should be described.   
 
(iii) Elimination diet: a form of dietary modification. A diet designed to detect what 
ingredient in the food causes symptoms in the patient, foods items of which the patient may 
be sensitive are withdrawn separately and successfully from the diet until the item that causes 
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the symptoms is discovered. Used frequently in patients with faecal incontinence, urgency 
and urgency incontinence (bladder diet) [69,70]. 
 
(iv) Physical activity: any body movement produced by the skeletal muscles that result in a 
substantial increase over the resting energy expenditure. Physical activity can be done at 





4.2.B. Counseling  
The provision of professional assistance and guidance in resolving personal or psychological 
problems [7]. Counselling may be is part of any clinician’s management.   
 
(i) Patient education: providing patients with knowledge and understanding of their 
condition thereby empowering them to play an active role in its management [73]. 
Figure 8: Patient education of pelvic floor muscle function (with permission from Women’s 
and Men’s Health Physiotherapy) 
 
(ii) Motivational interviewing: a directive, client-centered counselling style for eliciting 
behaviour change by helping clients to explore and resolve ambivalence. Compared with 
                                                 
23
 Increase of physical activity level may affect UI positively via weight reduction in obese 
persons. Conversely, several studies have shown that there is a high prevalence of UI in 
physically active women during exercise (especially during high impact activity, defined as 
running and jumping). Strenuous exercise/work has been suggested as a risk factor for 
development of pelvic floor dysfunctions [71]. A well- functioning pelvic floor will respond 
before and during an increase in intra-abdominal pressure. 
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nondirective counselling, it is more focused and goal-directed. The examination and 
resolution of ambivalence is its central purpose, and the counsellor/clinician is intentionally 
directive in pursuing this goal [74]. 
 
(iii) Coping strategies: intervention aimed at helping patients to live with the condition as 
best as possible under the circumstances, to regain a feeling of being in control, to adjust their 
lifestyle where necessary and to take a positive rather than negative approach [73]. 
  
(iv) Self-care:  the set of activities that comprise daily living, such as bed mobility, transfers, 
ambulation, dressing, grooming, bathing, eating, and toileting [5].  
 
(v) Self-help: various methods by which individuals attempt to remedy their difficulties 
without making use of formal care providers [5]. 
 
 (vi) Self-efficacy: an individual’s belief that he or she is capable of successfully performing a 
certain set of behaviors [75]. 
 
4.3. Scheduled voiding regimes  
Toileting on a fixed schedule around the patient’s normal voiding pattern which includes a 
progressive voiding schedule using relaxation and distraction techniques for urgency 
suppression [76]. Scheduled voiding regimes have been categorised as: bladder training, 
timed voiding, habit training and prompted voiding [71].  
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4.3.A. Bladder training  
(Also referred to in the past as bladder drill, bladder discipline, bladder re-education, bladder 
re-training). 
A program of patient education along with a scheduled voiding regimen with gradually 
adjusted voiding intervals. Specific goals are to correct faulty habit patterns of frequent 
urination, improve control over bladder urgency, prolong voiding intervals, increase bladder 
capacity, reduce incontinent episodes and restore patient confidence in controlling bladder 
function
24
 (modified from Moore et al) [71].  
 
4.3.B. Timed voiding 
A passive toileting assistance program, initiated and maintained by caregivers for patients 
who cannot participate in independent toileting. It is a fixed voiding schedule [71].  
 
4.3.C. Habit training  
A toileting schedule matched to the individual’s voiding patterns based on their voiding diary. 
The toileting schedule is assigned to fit a time interval that is shorter than the person’s normal 
voiding pattern and precedes the time period when incontinent episodes are expected [71]. 
 
4.3.D. Prompted voiding  
Is used to teach people to initiate their own toileting through requests for help and positive 
reinforcement from caregivers, often done in combination with a scheduled voiding regimens, 
typically every two hours [71]. 
                                                 
24
 Ideally the voiding intervals should be increased by 15-30 minutes each week, according to 
the patient’s tolerance to the schedule, until a voiding interval of 3-4 hours is achieved.  Use 
of a bladder diary is recommended for self-monitoring of progress [76]. 
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4.4 Other techniques for bladder and bowel control 
Doing something that takes the mind off the condition. Distraction techniques utilized in 
urgency may include (but are not limited to) count backwards from 100 in 7 seconds, recite a 
poem, do breathing exercises, read or work.  
 
4.4.B. Urgency suppression techniques 
Methods/manoeuvres used to decrease the feeling of urgency which may include, but are not 
limited to: distraction, PFM contraction, perineal pressure such as sitting on a hard chair, 
relaxation and breathing, toe curling or plantar flexion of the ankle. 
 
4.4.C. Double voiding 
The patient is taught to urinate, relax and attempt to urinate again [64]. 
 
4.4.D. Defecatory dynamics  
A postural and respiratory technique to aid defaecation.  The mechanics involves co-
ordination of the diaphragm, abdominal and pelvic floor muscles, with intent to maintain the 
rectal support whilst releasing the anal outlet with sufficient expulsion to be effective [77,78].  
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4.4.E. Bowel habit training 
The training aim to establish a regular, predictable pattern of bowel evacuation by patient 
teaching and adherence to a routine to achieve a controlled response to bowel urgency
25
 
(modified from NICE guideline) [80].   
 
4.5. Exercise/exercise training  
Exercise is a form of leisure-time activity that is usually performed on a repeated basis over 
an extended period of time (exercise training) with specific external objectives such as 
improvement of fitness, physical performance, or health [72]. Exercise training includes: 
endurance training, strength training, flexibility training and motor control (including 
balance), all of which may apply to the pelvic floor muscles. 
 
4.5.A Therapeutic exercise / exercise therapy  
Exercise interventions directed toward maximizing functional capabilities. A broad range of 
activities intended to improve strength, range of motion (including muscle length), 
cardiovascular fitness, flexibility, or to otherwise increase a person’s functional capacity [5]. 
 
(i) Rehabilitation / re-education 
                                                 
25
 A bowel habit intervention may:  encourage bowel emptying at a specific time of day, 
mainly after a meal (to utilise the gastrocolic response), encourage people to adopt a sitting 
or squatting position where possible while emptying the bowel, teach people techniques to 
facilitate bowel evacuation and stress the importance of avoiding straining [79-81]. 
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Helping individuals regain skills and abilities that have been lost as a result of illness, injury 
or disease, disorder, or incarceration. The restoration of a disabled individual to maximum 
independence commensurate with his or her limitations [5].  
 
4.5.B. Mode of exercise training 
Not only the type of activity to be performed (for instance, fast walking, jogging, or 
swimming, strength training), but also the temporal pattern of activity that is recommended 
(that is, continuous or intermittent activity), with a detailed specification of the duration of 
exercise and rest periods in the case of intermittent activity bouts [72]. Authors are 
encouraged to specifically describe all components of mode of exercise and dose provided. 
 
(i) Muscle training: exercise to increase muscle strength, endurance, power, flexibility or 
relaxation. 
 
a. Strength training: training with high resistance (close to maximal contractions) and few 
repetitions with the aim to increase muscle volume and neural adaptations. 
b. Resistance: the amount of force opposing a movement [45]. 
c. Resistance devices: any object used to increase resistance to contraction e.g. hand weights. 
d. Vaginal resistance device: objects inserted into the vagina or rectum that are inflated or 
spring loaded devices to increase resistance to contraction. 
e. Local muscle endurance training: training with low load and high number of repetitions 
or holding the contraction over time. 
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f. Muscle power training: all training with the aim to generate power; can be close to 
maximal contraction training and/or rapid contractions
26
. 
g. Overload: a situation in which the body is required to perform exercise beyond that which 
the neuromuscular system is accustomed to during routine activities. A training adaptation 
occurs in response to a progressive “overload” [82].  
h. Progressive overload: the gradual increase of stress placed upon the body during exercise 
training [83]. 
i. Detraining: cessation of training, but also planned or unplanned reduced volume or 
intensity of training [84].  
j. Maintenance training: maintenance training refers to a program designed to prevent loss 
of previous level of functioning.  
k. Isometric/static contraction:  a muscular action during which no change in the length of 
the total muscle or joint angle takes place [84]. 
l. Isotonic contraction: a muscular action during which the tension developed by the muscle 
remains almost constant while the muscle shortens [85]. 




n. Repetition: the completion of a whole cycle from the starting position, through the end of 
the movement and back to the start. [82]. E.g. one PFM contraction with relaxation. 
o. Set:  the number of times the desired number of repetitions is performed [39]. E.g. 3 sets of 
12 PFM contractions. 
                                                 
26
 Speed changes little with training. Thus, power is increased almost exclusively through 
gains in strength [41]. 
27
 PFM training can be isometric, concentric or eccentric or combination of any of these. 
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p. Pelvic floor muscle training (PFMT): exercise to improve PFM strength, endurance, 
power, relaxation or a combination of these parameters.  
q. Kegels: a PFM contraction or PFM exercise. This term is named after Arnold Kegel, an 
American gynaecologist who first described the clinical effect of PFMT in the late 1940s 
[54]. We recommend the use of the term PFMT (not the word Kegels’) to refer to exercises 
which specifically target the PFM. 
r. Individualized pelvic floor muscle training: an individual PFM program aimed to 
improve the specific deficiencies in PFM structure or function based on assessment of the 
woman’s ability to contract the PFM. 
s. Supervised pelvic floor muscle training:  a PFM training program taught and monitored 
by a health professional/clinician / instructor.  
t. Group pelvic floor muscle training: PFM training conducted in an exercise class [86].   
Class participation may occur with or without prior individualized PFM instruction
28
. 
u. Home training/home PFM exercise program:  an unsupervised PFM training program, 
which the individual performs at home. 
v. Weighted vaginal cones: objects of different shapes, sizes and weight which are inserted 
into the vagina above the level of the PFM with the aim of providing sensory biofeedback and 
load on the PFM to increase muscle recruitment and strength
29
 [87].  
 
                                                 
28
 Whether PFMT is performed with or without prior assessment of ability to contract should 
be reported.  
29
 The original shape was conical, however different shapes are currently available. 
Maintenance of the weight in position can be challenged via different body positions and 
activities. 
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(iii) Facilitation technique: any method to increase recruitment/response of a non-
responding muscle. In the case of non-contractile or very weak PFMs, this may include a 
quick stretch to the PFM with tapping or stretching the PFM digitally. An overflow effect 
from a strong contraction of a nearby synergistic muscle (e.g. external rotators) may also 
assist facilitation or recruitment of PFMs. 
 
4.5.C. Dose-response issues related to exercise training 
(i) Dose-response: amount/volume of training and its effect on, the speed of, and degree of 
effect of the training program. 
 
(ii) Frequency of exercise: the number of activity sessions per day, week, or month [39]. 
 
(iii) Duration of exercise: the unit of time (number of seconds / minutes) of activity in each 
repetition or session, e.g. a 10 sec PFM contraction [39]. It also refers to the length of the 
whole training period (intervention); e.g. 3 / 6 months. 
 
(iv) Intensity: the amount of resistance used or effort associated with the physical activity 
[39]. For strength training, it is often expressed as % of “one repetition maximum: 1RM (the 
maximum load a person can lift once), e.g 70% of max [82]. 
 
(v) Session / bout: the block of time devoted to the training e.g a one hour session [82]. 
 
4.5.D. Relaxation training 
(i) Relaxation: the ability to control muscle activity such that muscles not specifically 
required for a task are quiet, and those which are required are fired at the minimal level 
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needed to achieve the desired results [88]. Relaxation “can be considered as a motor skill in 
itself because the ability to reduce muscle firing is as important to control as is generation of 
firing” [46].  
 
a. General relaxation technique: a technique which involves  the whole body, with the aim 
to effect a global  relaxation including decrease in skeletal and smooth muscles, decrease in 
heart rate, respiration rate and increase in parasympathetic activity. General relaxation 
techniques can also be used with the aim to relax local muscles. 
 b. Progressive muscular relaxation (also known as Jacobsen’s technique): monitoring 
tension in each specific muscle group, by contracting, then relaxing the tension, with attention 
paid to the contrast between tension and relaxation [89]. This type of relaxation is also termed 
“contract-relax”. 
c. Meditation: a practice of concentrated focus upon a sound, object, visualization, the breath, 
movement, or attention itself in order to increase awareness of the present moment, reduce 
stress, promote relaxation, and enhance personal and spiritual growth [90]. 
d. Mindfulness: intentionally bringing one's attention to the internal and external experiences 
occurring in the present moment. Mindfulness is often taught through a variety of meditation 
exercises [91]. 
e. EMG relaxation techniques: techniques to decrease EMG muscle activity or activation 
through a variety of methods including conscious effort to relax.  
 
4.5.E. Stretching  
(i) Stretching (also referred to as flexibility training when the method is used on skeletal 
muscles where increased range of motion over joints is the aim): the application of an 
external force to muscle and connective tissue to elongate it in the direction opposite to its 
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shortened position. This can be done in parallel with or perpendicular to muscle fibre 
direction. For the PFM this can be applied as a widening of the levator hiatus in the axial 
plane (latero-laterally) via a digit or use of dilator, or a caudal movement (via a 
straining/bearing down manoeuvre) in the sagittal plane.  
 
a. Dilator therapy: a conical or cylindrically-shaped device (made of an inert material) 
inserted intra-vaginally or intra-anally, with the aim to increase the flexibility or elasticity of 
the soft tissues via application of a prolonged elongation or stretch. Dilators may also be used 
as a de-sensitizer device, in order to reduce fear, anxiety or pain associated with vaginal touch 
and in conjunction with vaginismus or sexual pain. When combined with EMG, dilators can 
be used to train PFM relaxation during penetration. Dilators may also be used to increase 
tolerance of skin to sliding when the dilator is moved in and out. 
 
4.5.F. Functional training  
Training in tasks of daily living and self-care activities e.g. squatting to train quadriceps and 
gluteal muscles.  
 
(i) Functional PFM training: training and exercises which incorporate a correct PFM 
contraction into activities of daily living such as lifting, transferring out of bed, or sneezing. A 
PFM contraction prior to a rise in intra-abdominal pressure e.g. a cough (“the Knack”) is part 
of functional PFM training. 
 
(ii) Coordination training: the ability to use different parts of the body together smoothly 
and efficiently [7]. Related to PFM training, coordination training means PFM contraction 
with other muscles or other muscle groups e.g. respiratory muscles.   
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(iii) Functional mobility training: an intervention directed at improving physical ability to 
perform a daily task. For voiding / defecation, this may include: gait training, transfer 
training, stair training, and other mobility training to improve speed and safety in reaching the 
toilet.  
 
4.6. Biofeedback training  
4.6.A. Feedback  
Sensory information that is available as the result of an activity that a person has performed. It 
can be provided by an intrinsic source (from within the individual), or an extrinsic source 
(from the clinician), and can occur concurrently with the activity or post-activity.  E.g. verbal 
information from the clinician to the patient during or following PFM assessment
30
 [92].  
4.6.B. Biofeedback   
Use of an external sensor to give an indication on bodily processes, usually in the purpose of 





                                                 
30
 PFM feedback can be provided by the therapist or patient during manual palpation 
internally or externally, or with a mirror. The purpose of feedback is to increase accuracy of 
contraction for maximum benefit. 
31
 Biofeedback can be either visual, auditory or both. Biofeedback is not a treatment on its 
own. It is an adjunct to training and can be used to help the patient be more aware of muscle 
function, and to enhance and motivate patient effort during training [94]. The correct 




4.6.C. EMG Biofeedback Unit Instrumentation 
 
(i) EMG signal amplitude: amount of microvolts (uV) a muscle is generating [95]. EMG 







(ii) Artifact: extraneous information non- recognizable in EMG signal from sources other 




(iii) Cross talk: muscle activity from nearby muscles which can artificially increase EMG 




(iv) Dual channel EMG: use of two channels to monitor two separate muscle or muscle 
groups at the same time such as the PFM and abdominal muscles with the goal to either 
                                                                                                                                                        
32
 Types of pelvic floor muscle biofeedback include: perianal, vaginal and anal surface EMG, 
urethral, vaginal or anal manometry, vaginal dynamometry, real-time ultrasound [94]. 
33
 Clinicians are to be cautious in regard to the interpretation of the information as many 
factors influence amplitude including muscle activity, skin conductance, and artifact.   
34
 "EMG amplitude does not equal force" [95]. More microvolt activity means more muscle 
activity but does not always mean more strength.  
35
 Artifact examples: movement or contact quality artifact, cross talk, heart rate, skin 
electrode shear, electrode bridging, and others. 
36
 Minimizing cross talk is essential in research for quality EMG tracings.  
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promoting synergist activity or to reduce EMG activity of one muscle while increasing the 
other.  
 





4.6.D. PFM EMG Assessment   
Use and interpretation of surface EMG recording of a muscle for rehabilitation purposes 
should be done cautiously recognizing the main goal is qualitative description of muscle 
activation pattern not qualitative diagnosis.  
 
(i) Baseline muscle activity: amount of microvolts generated by the target muscle during 
rest
38
.   
 
(ii) Peak microvolts: highest EMG amplitude achieved.  
 
(iii) Slow recruitment: slow initiation of muscle activation contraction
39
.  
                                                 
37
 Recording with surface electrodes is prone to artifact and cross talk. The user should be 
trained appropriately and understand the limit of the EMG instrument and of the 
methodology.  It is not within the scope of this document to define all EMG terms. Readers 
are referred to other texts for further terminology [95,96]. 
38
 Baseline EMG reading can be influenced by many factors and therapists must take into 
account patient's symptoms, digital palpation results, overall tension of the patient, possibility 
of artifact, and other factors in determining the meaning of the baseline muscle activity. 
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(iv) Slow de-recruitment or slow latency to return to baseline: slow relaxation of the 
muscle contraction
40
 [96].  
 
(v) Inconsistent resting baseline: variation of baseline between contractions, between sets, 
or between days may be related to a change in patient symptoms e.g hypertonic PFM.   
 
(vi) Excessive accessory muscle contraction: increased amplitude in accessory muscles 
often resulting in cross talk and indicative of poor isolation of target muscle contraction.  
 
4.6.E. PFM EMG training 
(i) Up-training: EMG biofeedback training to increase the EMG activity of a hypotonic 
muscle with low EMG activity
41
 [95].  
 





                                                                                                                                                        
39
 Slow recruitment can be symptomatic of leakage during coughing and sneezing when a 
quick muscle contraction is needed to counteract increased intra-abdominal pressure. 
40
 Slow de-recruitment can be indicative of an hypertonic PFM. 
41
 The general principles of strength training are the same with and without biofeedback. (See 
mode of exercise training and dose response issues) 
42
 The general principles of relaxation training are the same with and without biofeedback. 
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4.7. Manual therapy  
A clinical approach utilizing skilled, specific hands-on techniques, including but not limited 




4.7.A. Joint therapies 
(i) Mobilization: skilled passive movement of a skeletal joint which includes graded passive 
oscillations at the joint to improve joint mobility e.g. movement of the coccyx. 
 
(ii) Manipulation: a passive (for the patient) therapeutic movement, usually of small 
amplitude and high velocity, at the end of the available joint range [5]. Manipulation is a 




4.7.B. Soft tissue therapies 
 (i) Touch de-sensitization: use of finger / hand, vibration or device to reduce 
hypersensitivity of soft tissues to touch / contact. 
 
(ii) Massage: the manipulation of the soft tissues of the body for the purpose of affecting the 
nervous, muscular, respiratory, and circulatory systems [5].  
 
                                                 
43
 Manual therapy is used to treat soft tissues and joint structures for the purpose of 
modulating pain; increasing range of motion; reducing soft tissue oedema; inducing 
relaxation; improving contractile and non-contractile tissue extensibility, and/or stability; 
facilitating movement, and improving function.  This broad group of skilled hands-on 
treatments can be divided into two groups: joint therapies and soft tissue therapies. 
44
 Neither mobilization nor manipulation should be used when referring to muscle. 
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(iii) Abdominal massage: therapist or self-directed massage of the abdominal wall with the 
aim to stimulate peristalsis and relieve the symptoms of constipation. Generally the technique 
follows the ascending, transverse and descending colon to aid emptying. The effect may be 
mechanical or sensory [97]. 
 
(iv) Myofascial release techniques: the use of deep friction and stroking of the fascia of the 
body to improve the ability of the fascia to deform and move within the body [5]. 
 
(v) Skin rolling: a manual technique in which skin is pulled away from the underlying 
structures and elongated in various directions.  
 
(vi) Scar massage: a specific application of soft tissue mobilization to adherent scar.  
 
(vii) Perineal massage: intra-vaginal massage by the woman, her partner or the clinician. 
Technique includes alternating downward and sideward pressure, using thumb and forefinger 
and a natural oil, with the aim to stretch and elongate the tissue in preparation for vaginal 
childbirth, or for treatment of adherent scaring in the perineum [98].  
 
(viii) Transverse friction: the operator's fingertip is placed on the exact site of the lesion and 
rubbed firmly across the direction of the fibers of the affected tissue [99].    
 
(ix) Thiele’s massage: per rectal digital massage of levator ani, sweeping lengthwise along 




(x) Trigger point treatment (TrP): (sometimes called myofascial trigger point treatment): 
soft tissue mobilization specifically targeting trigger points and may include ischemic 
pressure, massage, myofascial release, electrotherapy, ultrasound, laser, spray-and-stretch, 
injection (variety of chemicals including local anesthetic, botox or steroids), dry needling 




4.8. Thermal modalities  
4.8.A. Cold treatment / cryotherapy 
The application of ice for therapeutic purposes. It is used in the initial management of acute 
musculoskeletal injuries, in order to decrease oedema through vasoconstriction and reduce 
secondary hypoxic injury by lowering the metabolic demand of injured tissues [30].  
 
4.8.B. Heat treatment (moist or dry) 
The application of heat to a body part, with the aim to relieve pain and/or stiffness. Usually 
applied when an injury is older than 48 hours. 
 
4.9. Electrical therapy  
Use of electric potential or currents to elicit therapeutic responses. Current may be directed at 
motor or sensory functions. It is not within the scope of this document to define all electrical 
stimulation terms. Readers are referred to more complete text-books [101]. 
 
                                                 
45
 Trigger points as the cause of myofascial pain is controversial [17]. 
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4.9.A. Electrical muscle stimulation (EMS) (also known as neuromuscular electrical 
stimulation (NMES) or electromyo stimulation) 
The application of electric impulses directly to striated pelvic floor muscle (end-plate) to 
facilitate contraction. EMS is often referred to as pelvic floor muscle electrical stimulation 
(PFES) or functional electrical stimulation. PFES is the application of electrical current to the 
pelvic floor muscle [102]. All of these stimulations may (indirectly) cause inhibition of the 
detrusor contraction.  
 
Figure 9: Myomed pelvic floor machine, including electrical stimulation (with permission 
from Enraf-Nonius) 
 
4.9.B. Mode of application  
(i) Surface electrodes: non-invasive placement of electrodes including intra-vaginal and 
intra-anal electrodes; in contrast to electrodes which pierce the skin, i.e. needle stimulation. 
 
a. Non-invasive electrical nerve stimulation [103,104] or transcutaneous electrical nerve 
stimulation (TENS): the application of electrical energy to stimulate cutaneous nerve and 
peripheral motor nerves, via suprapubic, perineal or sacral placement of electrodes, or other 
external sites, or intra-vaginal or intra-anal plug electrodes.  
 
There are two main types of electrical stimulation with surface electrodes: 
- Long-term or chronic electrical stimulation is delivered below the sensory threshold. It 
aims to inhibit detrusor activity by afferent pudendal nerve stimulation. The device is used 6 
to 12 hours a day for several months [105]. 
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- Maximal neuromuscular electrical stimulation applies a high-intensity stimulus, set just 
below the pain threshold. It aims to improve urethral closure, via striated muscle recruitment. 
Detrusor inhibition by afferent pudendal nerve stimulation has also been suggested as a 
mechanism of effect [103]. Maximal electrical stimulation (35-70Hz) is applied over short 
duration (15 to 30 minutes), is used several times per week (and up to 1 to 2 times daily), and 
may be provided via in-clinic application or via portable devices at home) [106-108].  
 
(ii) Percutaneous electrical nerve stimulation (PENS): a therapeutic modality that 
stimulates peripheral sensory nerves performed with a (few) needle electrode(s) that are 
placed in close proximity to the area to stimulate. - Percutaneous neuromuscular electrical 
stimulation (e.g. posterior tibial nerve stimulation): a peripheral neuromodulation technique, 
in which the posterior tibial nerve is electrically stimulated three fingerbreadths above the 
medial malleolus, via insertion of a percutaneous needle electrode. This is coupled with an 
adhesive reference surface electrode placed near to the needle. This intervention is offered to 
patients with overactive bladder (OAB) [109-111]. 
 
4.9.C. Electrophysiological parameters 
(i) Electrical Current: the flow (current) of electrons (electricity) from an electron source 
(stimulator) the wires and electrodes used to deliver such an electrical current to soft tissues 
[112].  
 
There are 3 types of current: direct, alternating and pulsed. – 
a. Direct: the continuous, unidirectional flow of charged particles for 1 second or longer, the 
direction of which is determined by the polarity selected. Polarity refers to two oppositely 
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charged poles, one positive and one negative. Polarity determines the direction in which 
current flows [112].  
b. Alternating: the continuous, bidirectional flow of charged particles, for one second or 
longer, relative to the isoelectric baseline [112].  
c. Pulsed: the non-continuous, interrupted and periodic flow of direct (DC) or alternating 
(AC) currents [112].  
 
Currents used in therapy:  
a. Faradic current:  an alternating and interrupted low frequency current capable of 
stimulating (depolarizing) nerve fibers through the skin using surface stimulating electrodes. 
It is used to stimulate innervated muscles causing them to contract [113]. 
b. Transcutaneous electrical nerve stimulation (TENS):  an alternating and interrupted low 
frequency current capable of stimulating (depolarizing) nerve fibers through the skin using 
surface stimulating electrodes for pain modulation or pain relief [112]. 
c. Interferential current:  (IFC), a medium frequency, amplitude modulated electrical 
current that results from the interference (hence the word interferential) caused by crossing 
two or more medium frequency alternating sine-wave currents with different carrier 
frequencies. The carrier frequency of theses medium alternating sine wave currents ranges 
between 2000 and 5000 cycles per seconds [112].   
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4.9.D. Neuromuscular Electrical stimulation parameters46 
(i) Pulse frequency (or rate): the number of pulse cycles that are generated per unit of time 
(seconds). This is reported as hertz (Hz) [112].  
  
(ii) Pulse width: the determined period of time elapsing from the beginning to the end of one 
pulse cycle, usually express in microseconds or milliseconds [112].  
 
(iii) Current amplitude: the magnitude of current relative to the isoelectric baseline, 
expressed in amperes (A). The current amplitude of therapeutic electrical stimulators ranges 
in micro to milliamperes [112]. 
  
(iv) Train: the continuous series of pulse cycles over time, usually lasting seconds. For 
example, a train of impulses may be the results of successive pulse cycles delivered at 50 Hz 
for a duration of 5 seconds [112]. 
 
(v) Train ramp-up time and ramp-down time: ramp-up time is the time elapse from the 
onset (or baseline) to plateau current amplitude (or maximum) of the train, whereas ramp-
down time is the time elapsed from the plateau current amplitude to zero baseline
47
 [112].  
                                                 
46
 Depending on the particular device being used, type of electrical current, the specific 
health problem and condition being treated, the individual’s needs and circumstances, many 
electrical stimulation parameters may be adjusted by the therapist administering the 
treatment. 
47
 The slower the current intensity rise to the pre-set amplitude or threshold level, the more 
comfortable the stimulation may feel. Conversely, the faster the ramp, or the more vertical the 
ramping up signal, the more discomfort may be felt. 
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(vi) Duty cycle (D): it is the ratio of ON-time to the summation of ON-time + OFF time, 
expressed as a percentage (duty cycle = (ON)/(ON +OFF time) x 100. E.g.: a duty cycle of 
20% is calculated when the ON- and OFF times equal 10 and 40 seconds, respectively [112].   
 
(vii) Impedance (electric resistance): the opposition of our biological tissues to the flow of 
an electrical current. Measured in ohms and designated by Z. [112].  
 
(viii) Evoked potentials: electrical potentials recorded from the nervous system following a 
delivered stimulus. Not pertinent for electrical stimulation as an intervention. 
 
4.10. Magnetic stimulation  
(or Extracorporeal Magnetic Innervation (ExMI): a pulsed magnetic technology developed for 
the transmission of nerve impulses which aims to cause pelvic floor muscle contraction. 
Persons receive therapy by sitting in a chair, which contains the device that produces the 
pulsing magnetic fields.  
 
4.11. Mechanical devices  
4.11.A. Intravaginal devices 
Devices intended to provide some support to the bladder neck and possibly some compression 
to the urethra, to correct urinary stress incontinence. These can be traditional tampons, 
pessaries and contraceptive diaphragms and devices designed specifically to support the 
bladder neck (removable reusable intra-vaginal ring or single-use disposable devices [114]. 
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4.11.B. Anal plugs 
Types of containment devices that aim to block the loss of stool to control faecal 
incontinence. Plugs come in different designs, sizes and composition such as polyurethane 
and polyvinyl-alcohol
48
 [115].  
 
4.11.C. Rectal irrigation 
The use of liquid solutions given by enema to remove material from the rectum [116]. 
 
4.11.D. Urethral plugs 
Intra-urethral devices are types of containment products that aim to block urine leakage [117]. 
 
4.11.E. Pessaries 
Intravaginal devices used to try to restore the prolapsed organs to their normal position and 
hence to relieve symptoms. Vaginal pessaries can be broadly divided into two types: support 
pessaries (Ring, Ring with support, Gehrung, Hodge, Shelf) and space filling pessaries 
(Doughnut, Gellhorn, Cube, Inflatable pessaries) [117-119]. 
 
4.12. Hygiene  
4.12.A. Bladder hygiene 
Prevention of urinary tract infection by using techniques such as wiping the urethral meatus 
with clean wipes in an anterior-to-posterior direction after voiding, wearing clean underwear, 
keep the genital area clean, and emptying the bladder before and after sexual intercourse 
[120,121].   
 
                                                 
48
 Terminology for female Anorectal Dysfunction[11].  
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4.12.B. Vulval hygiene 
Maintaining a clean perineum by means of washing the area on a regular basis, and wearing 
cotton underwear. To avoid vulval irritation, shampoo, perfumed creams or soap should be 
avoided in the vulval area [122].  
 
4.12.C. Anal hygiene 
Anal hygiene involves keeping the peri-anal region clean, especially important when fecal 
seepage is present. Advice includes using soft toilet paper or moist wipes (avoiding any with 
an alcohol base), always wiping from to back, washing after a bowel movement, then gently 
patting dry [97]. To avoid irritation from products, follow vulval hygiene advice above.  
 
4.12.D. Vaginal lubricants 
Pharmacologic preparations aimed to reduce friction during coital or any other sexual activity 
and thereby alleviate dyspareunia [123], or to reduce discomfort associated with a clinical 
(per vaginum or per rectum) examination. Pharmacological preparations and natural plant-
based oils may be used.  
 
4.13. Aids and appliances  
4.13.A. Absorbent products 
Products which have been specifically developed to help manage leakage or soiling such as 




Urinary catheters are small tubes inserted via the urethra or into the bladder suprapubically, to 
allow drainage of urine. Catheters are made of plastic, latex, teflon or silicone, and may be 
impregnated with antiseptic or antibiotic solution [125]. 
 
(i) Self-catheterization: a procedure performed intermittently to empty the bladder by 
inserting a catheter into the urethra when normal voiding is not possible or the bladder cannot 
be emptied completely. If a care-giver undertakes this procedure it is usually a sterile 
procedure; if a patient undertakes it, it is termed "self-catheterization" and is generally a clean 
rather than a sterile procedure [126-128]. 
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Figure 1: Levator hiatal dimensions measured using trans-perineal ultrasound (with 
permission from Ingeborg Hoff Braekken) 
 
Figure 2:  Digital palpation of the pelvic floor muscles (with permission from subjects in 
photo and photographer Andreas Birger Johansen)  
 
Figure 3: Peritron manometer (with permission from Laborie) 
 
Figure 4: Graphical illustration of pelvic floor muscle manometry readings (with permission 
from illustrator Ingeborg Hoff Braekken) 
 
Figure 5: Ann Arbor, USA Dynamometer speculum. Note that the bills of the speculum are 
covered by a condom in actual use (with permission from Ashton-Miller JA, Zielinski R, 
DeLancey JO, Miller JM.) 
 
Figure 6: Montreal, Canada, Dynamometer apparatus (with permission from Chantale 
Dumoulin) 
 
Figure 7: Verity Medical NeuroTrac Myoplus Pro surface EMG biofeedback apparatus (also 
incorporating electrical stimulation (with permission from Quintet, Norway) 
 
Figure 8: Patient education of pelvic floor muscle function (with permission from Women’s 
and Men’s Health Physiotherapy) 
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Figure 9: Enraf-Nonius Myomed pelvic floor machine, including electrical stimulation (with 
permission from Enraf-Nonius). 
